RecentMedicalFindings.com
Summarizing relevant biomedical research!
nitrofurantoin     Bookmark and Share
Search webpages of this site (RecentMedicalFindings):
Didn't find what you wanted? Try it at BioMedLib™ !
Search directly on the biomedical articles using BioMedLib™ search engine:



1. Biomedical articles (top 50; 2009 to 2014)
1. |||||||||. 100%  Velema MS, Voerman HJ: DRESS syndrome caused by nitrofurantoin. Neth J Med; 2009 Apr;67(4):147-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] DRESS syndrome caused by nitrofurantoin.
  • Systemic side effects of nitrofurantoin are rare but can be life-threatening.
  • [MeSH-major] Acute Kidney Injury / chemically induced. Anti-Infective Agents, Urinary / adverse effects. Drug Eruptions / diagnosis. Eosinophilia / chemically induced. Nitrofurantoin / adverse effects. Shock / chemically induced

  • MedlinePlus Health Information. consumer health - Eosinophilic Disorders.
  • MedlinePlus Health Information. consumer health - Shock.
  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19581659.001).
  • [ISSN] 1872-9061
  • [Journal-full-title] The Netherlands journal of medicine
  • [ISO-abbreviation] Neth J Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 927AH8112L / Nitrofurantoin
  •  go-up   go-down


2. ||||||||.. 83%  Zhang Y, Zhou L, Unadkat JD, Mao Q: Effect of pregnancy on nitrofurantoin disposition in mice. J Pharm Sci; 2009 Nov;98(11):4306-15
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effect of pregnancy on nitrofurantoin disposition in mice.
  • We investigated the effect of pregnancy on nitrofurantoin (NFT) disposition in wild-type and Bcrp1(-/-) mice.
  • [MeSH-major] ATP-Binding Cassette Transporters / metabolism. Anti-Infective Agents, Urinary / pharmacokinetics. Nitrofurantoin / pharmacokinetics

  • HSDB. structure - NITROFURANTOIN.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2009 Wiley-Liss, Inc. and the American Pharmacists Association
  • [Cites] Br J Obstet Gynaecol. 1980 Feb;87(2):106-9 [7362796.001]
  • [Cites] Antibiot Chemother (1971). 1978;25:233-52 [352255.001]
  • [Cites] Naunyn Schmiedebergs Arch Pharmacol. 1980;315(2):167-75 [7207645.001]
  • [Cites] Clin Pharmacol Ther. 1981 Jun;29(6):808-16 [7226713.001]
  • [Cites] Semin Perinatol. 1981 Oct;5(4):310-4 [7302604.001]
  • [Cites] J Pharmacokinet Biopharm. 1983 Oct;11(5):529-45 [6668558.001]
  • [Cites] Cancer Chemother Pharmacol. 1990;27(1):27-32 [2245490.001]
  • [Cites] Clin Pharmacokinet. 1997 Nov;33(5):328-43 [9391746.001]
  • [Cites] J Pharm Sci. 1998 Mar;87(3):372-8 [9523992.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15665-70 [9861027.001]
  • [Cites] J Pharmacol Exp Ther. 1961 Jan;131:38-43 [13689519.001]
  • [Cites] Mol Pharmacol. 2005 May;67(5):1758-64 [15709111.001]
  • [Cites] Mol Pharmacol. 2005 May;67(5):1765-71 [15722455.001]
  • [Cites] AAPS J. 2005;7(1):E118-33 [16146333.001]
  • [Cites] Clin Pharmacokinet. 2005;44(10):989-1008 [16176115.001]
  • [Cites] Annu Rev Pharmacol Toxicol. 2006;46:381-410 [16402910.001]
  • [Cites] Clin Chim Acta. 2006 Nov;373(1-2):99-103 [16784736.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1295-304 [17082346.001]
  • [Cites] Antimicrob Agents Chemother. 2007 Feb;51(2):783-6 [17158945.001]
  • [Cites] Drug Metab Dispos. 2007 Feb;35(2):268-74 [17093006.001]
  • [Cites] Expert Opin Drug Metab Toxicol. 2007 Aug;3(4):557-71 [17696806.001]
  • [Cites] Drug Metab Dispos. 2007 Dec;35(12):2154-8 [17785426.001]
  • [Cites] Mol Pharmacol. 2008 Mar;73(3):949-59 [18079276.001]
  • [Cites] Clin Pharmacol Ther. 2008 Jul;84(1):95-103 [18167504.001]
  • [Cites] Clin Pharmacol Ther. 2008 Aug;84(2):248-53 [18288078.001]
  • [Cites] Pharm Res. 2008 Jun;25(6):1244-55 [18202831.001]
  • [Cites] Hepatology. 2001 Jan;33(1):140-7 [11124830.001]
  • [Cites] Cancer Res. 2001 Apr 15;61(8):3458-64 [11309308.001]
  • [Cites] J Clin Oncol. 2002 Jul 1;20(13):2943-50 [12089223.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2002 Sep;283(3):G757-66 [12181192.001]
  • [Cites] Neuroreport. 2002 Nov 15;13(16):2059-63 [12438926.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15649-54 [12429862.001]
  • [Cites] Eur J Clin Pharmacol. 2003 Oct;59(7):553-7 [12955370.001]
  • [Cites] Antimicrob Agents Chemother. 2004 Feb;48(2):430-6 [14742191.001]
  • [Cites] Cancer Res. 2004 May 1;64(9):3296-301 [15126373.001]
  • [Cites] Am J Obstet Gynecol. 2004 Aug;191(2):398-407 [15343213.001]
  • [Cites] Ann Pharmacother. 2004 Oct;38(10):1692-701 [15340129.001]
  • [Cites] Pharmacology. 1972;8(1):178-81 [4644646.001]
  • [Cites] Clin Pharmacol Ther. 1980 Aug;28(2):253-61 [7398192.001]
  • (PMID = 19422048.001).
  • [ISSN] 1520-6017
  • [Journal-full-title] Journal of pharmaceutical sciences
  • [ISO-abbreviation] J Pharm Sci
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / HD044404; United States / NICHD NIH HHS / HD / P50 HD044404-05
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Abcg2 protein, mouse; 0 / Anti-Infective Agents, Urinary; 927AH8112L / Nitrofurantoin
  • [Other-IDs] NLM/ NIHMS117693; NLM/ PMC2755645
  •  go-up   go-down


3. ||||||||.. 78%  Madani Y, Mann B: Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections. Prim Care Respir J; 2012 Sep;21(3):337-41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections.
  • Nitrofurantoin is commonly used for the treatment and prophylaxis of recurrent urinary tract infections (UTIs).
  • Although relatively rare, nitrofurantoin is one of the commonest causes of drug-induced pulmonary disease, which can be potentially serious and even fatal.
  • Patients on long-term nitrofurantoin should be reviewed and monitored regularly.
  • We report three cases of nitrofurantoin-induced lung disease in patients who were on long-term nitrofurantoin for UTI prophylaxis and present a brief review of the literature on this subject.
  • [MeSH-major] Anti-Infective Agents, Urinary / adverse effects. Lung Diseases / chemically induced. Nitrofurantoin / adverse effects

  • MedlinePlus Health Information. consumer health - Lung Diseases.
  • HSDB. structure - NITROFURANTOIN.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Urol. 2013 Oct;190(4):1252 [24029321.001]
  • (PMID = 22836745.001).
  • [ISSN] 1475-1534
  • [Journal-full-title] Primary care respiratory journal : journal of the General Practice Airways Group
  • [ISO-abbreviation] Prim Care Respir J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 927AH8112L / Nitrofurantoin
  •  go-up   go-down


Advertisement
4. ||||||||.. 77%  Viejo MA, Fernández Montes A, Montes JV, Gómez-Román JJ, Ibarbia CG, Hernández JL: [Rapid resolution of nitrofurantoin-induced interstitial lung disease]. Arch Bronconeumol; 2009 Jul;45(7):352-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Rapid resolution of nitrofurantoin-induced interstitial lung disease].
  • We report the case of a 40-year-old woman diagnosed with interstitial lung disease due to long-term nitrofurantoin therapy.
  • This case shows that nitrofurantoin-induced lung disease may run a benign course and respond favorably to corticosteroids, even when there is radiographic evidence of established lung fibrosis.
  • Transbronchial biopsy might be useful for assessing the reversibility of pulmonary lesions associated with nitrofurantoin.
  • [MeSH-major] Anti-Inflammatory Agents / therapeutic use. Lung Diseases, Interstitial / chemically induced. Nitrofurantoin / adverse effects. Prednisone / therapeutic use


5. ||||||||.. 76%  Cooper IF, Siadaty MS: 'Organic Chemicals' associated with 'Nitrofurantoin Susceptibility': Top Publications. BioMedLib Review; OrganicChemical;NitrofurantoinSusceptibility:705729237. ISSN: 2331-5717. 2014/4/26
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Organic Chemicals' associated with 'Nitrofurantoin Susceptibility': Top Publications.
  • Background: There are articles published each month which present 'organic chemical' for 'nitrofurantoin susceptibility'.
  • However these articles are spread across thousands of journals, and there are many types of 'organic chemical'.
  • Hoo R et al: Potential unreliability of nitrofurantoin disks in susceptibility testing.
  • Karlowsky JA et al: Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
  • Babakir-Mina M et al: Antibiotic susceptibility of vancomyin and nitrofurantoin in Staphylococcus aureus isolated from burnt patients in Sulaimaniyah, Iraqi Kurdistan.
  • Anklesaria P et al: In vitro susceptibility of urinary pathogens to trimethoprim, nitrofurantoin and trimethoprim--nitrofurantoin combination.
  • Patil P et al: In vitro susceptibility of urinary pathogens to trimethoprim, nitrofurantoin and trimethoprim-nitrofuratoin combination.
  • Babakir-Mina M et al: Author response to laboratory detection of MRSA. Comment on "Antibiotic susceptibility of vancomyin and nitrofurantoin in Staphylococcus aureus isolated from burnt patients in Sulaimaniyah, Iraqi Kurdistan".
  • Obaseiki-Ebor EE: Enhanced Escherichia coli susceptibility to nitrofurantoin by EDTA and multiple aminoglycoside antibiotics resistance mutation.
  • Jasińska B et al: [Susceptibility to nitrofurantoin, biseptol and nalidixic acid of E. coli strains isolated from urine in the years 1983-1990].
  • SCHNEIERSON SS: 1959 bacterial susceptibility to nitrofurantoin as compared to 1953 to 1955.
  • Barry AL: Nitrofurantoin susceptibility test criteria.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 705729237.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


6. ||||||||.. 76%  Xavier BB, Vervoort J, Stewardson A, Adriaenssens N, Coenen S, Harbarth S, Goossens H, Malhotra-Kumar S: Complete Genome Sequences of Nitrofurantoin-Sensitive and -Resistant Escherichia coli ST540 and ST2747 Strains. Genome Announc; 2014;2(2)
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Complete Genome Sequences of Nitrofurantoin-Sensitive and -Resistant Escherichia coli ST540 and ST2747 Strains.
  • Widespread multidrug resistance in Escherichia coli has necessitated the reintroduction of older antibiotics, such as nitrofurantoin.
  • However, mechanisms by which resistance to nitrofurantoin emerges in E. coli are not well elucidated.
  • Toward this aim, we sequenced two nitrofurantoin-sensitive E. coli sequence types (ST540 and ST2747) and their four nitrofurantoin-resistant derivatives generated in vitro under aerobic and anaerobic growth conditions.

  • REBASE - The Restriction Enzyme Database. gene/protein/disease-specific - REBASE ref# 17449 .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24723707.001).
  • [ISSN] 2169-8287
  • [Journal-full-title] Genome announcements
  • [ISO-abbreviation] Genome Announc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3983296
  •  go-up   go-down


7. |||||||||. 113%  Mullerpattan JB, Dagaonkar RS, Shah HD, Udwadia ZF: Fatal nitrofurantoin lung. J Assoc Physicians India; 2013 Oct;61(10):758-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fatal nitrofurantoin lung.
  • Nitrofurantoin is a drug commonly used for urinary tract infections.
  • We present a case of an elderly lady receiving nitrofurantoin for her urinary tract infection who developed sudden acute lung injury to which she finally succumbed within a few weeks.
  • [MeSH-major] Anti-Infective Agents, Urinary / adverse effects. Lung Diseases, Interstitial / chemically induced. Lung Diseases, Interstitial / diagnosis. Nitrofurantoin / adverse effects

  • MedlinePlus Health Information. consumer health - Interstitial Lung Diseases.
  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24772739.001).
  • [ISSN] 0004-5772
  • [Journal-full-title] The Journal of the Association of Physicians of India
  • [ISO-abbreviation] J Assoc Physicians India
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 927AH8112L / Nitrofurantoin
  •  go-up   go-down


8. |||||||||. 107%  Leão RN, Barreto P, Leão RR, Ribeiro JV: Nitrofurantoin: cause of DRESS syndrome. BMJ Case Rep; 2013;2013
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nitrofurantoin: cause of DRESS syndrome.
  • Nitrofurantoin is a commonly used antibacterial drug because it has low side effects and a good antiurinary bacterial profile.
  • However, in this paper, we present a case of a nitrofurantoin-induced DRESS (drug reaction/rash with eosinophilia and systemic symptoms) syndrome in a 77-year-old woman.
  • At the emergency department, we found her developing eosinophilic pneumonia, anaemia and renal impairment that we relate to nitrofurantoin administration.
  • To our knowledge, this is the second published case report which evokes nitrofurantoin as a possible cause of DRESS syndrome.
  • [MeSH-major] Anti-Bacterial Agents / adverse effects. Drug Hypersensitivity Syndrome / etiology. Nitrofurantoin / adverse effects. Urinary Tract Infections / drug therapy

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • MedlinePlus Health Information. consumer health - Urinary Tract Infections.
  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23661654.001).
  • [ISSN] 1757-790X
  • [Journal-full-title] BMJ case reports
  • [ISO-abbreviation] BMJ Case Rep
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 927AH8112L / Nitrofurantoin
  •  go-up   go-down


9. |||||||||. 104%  Robinson C, Nyi PP: Probable nitrofurantoin-induced bronchiolitis obliterans with organizing pneumonia. Am J Health Syst Pharm; 2009 Nov 1;66(21):1919-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Probable nitrofurantoin-induced bronchiolitis obliterans with organizing pneumonia.
  • PURPOSE: A case of bronchiolitis obliterans with organizing pneumonia (BOOP) that developed after three years of nitrofurantoin therapy is described.
  • Imaging at the time of presentation revealed interstitial fibrosis consistent with nitrofurantoin-induced BOOP.
  • A diagnosis of BOOP was made, nitrofurantoin was discontinued, and the patient was discharged home on oxygen.
  • Seven weeks after nitrofurantoin discontinuation, the results of a chest radiograph and computed tomography scan were unchanged, but her symptoms had improved by 20%.
  • No improvement in subjective symptoms, in chest radiograph results, or in BOOP symptoms was seen after three months of prednisone discontinuation and five months of nitrofurantoin discontinuation.
  • CONCLUSION: An 89-year-old woman developed unresolving BOOP after three years of nitrofurantoin therapy.
  • [MeSH-major] Anti-Infective Agents, Urinary / adverse effects. Cryptogenic Organizing Pneumonia / chemically induced. Nitrofurantoin / adverse effects


10. |||||||||. 101%  Hardak E, Berger G, Krivoy N, Solomonov A, Yigla M: Nitrofurantoin pulmonary toxicity: neglected threat. Curr Drug Saf; 2010 Apr;5(2):125-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nitrofurantoin pulmonary toxicity: neglected threat.
  • Nitrofurantoin lung toxicity was diagnosed among ten patients receiving 50 mg/day to prevent recurrent urinary tract infection.
  • Large amount of data regarding unexpected, sometimes severe pulmonary toxicity during nitrofurantoin therapy should maintain a high index of suspicion for the drug usage among patients with non-resolving pulmonary symptoms.
  • [MeSH-major] Lung Diseases / chemically induced. Lung Diseases / diagnosis. Nitrofurantoin / adverse effects

  • MedlinePlus Health Information. consumer health - Lung Diseases.
  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19534638.001).
  • [ISSN] 2212-3911
  • [Journal-full-title] Current drug safety
  • [ISO-abbreviation] Curr Drug Saf
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United Arab Emirates
  • [Chemical-registry-number] 0 / Steroids; 927AH8112L / Nitrofurantoin
  •  go-up   go-down


11. |||||||||. 101%  Tan IL, Polydefkis MJ, Ebenezer GJ, Hauer P, McArthur JC: Peripheral nerve toxic effects of nitrofurantoin. Arch Neurol; 2012 Feb;69(2):265-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peripheral nerve toxic effects of nitrofurantoin.
  • OBJECTIVE: To investigate the role of skin biopsy in nitrofurantoin peripheral neuropathy.
  • DESIGN: We describe the clinical features and skin biopsies of 2 cases of non-length-dependent small-fiber neuropathy/ganglionopathy attributable to nitrofurantoin.
  • CONCLUSIONS: These distinct morphologic changes associated with nitrofurantoin have not been previously reported to our knowledge.
  • [MeSH-major] Anti-Infective Agents, Urinary / adverse effects. Nitrofurantoin / adverse effects. Peripheral Nervous System Diseases / chemically induced. Peripheral Nervous System Diseases / pathology

  • Genetics Home Reference. consumer health - small fiber neuropathy.
  • MedlinePlus Health Information. consumer health - Peripheral Nerve Disorders.
  • HSDB. structure - THIOPHENE.
  • HSDB. structure - GABAPENTIN.
  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22332195.001).
  • [ISSN] 1538-3687
  • [Journal-full-title] Archives of neurology
  • [ISO-abbreviation] Arch. Neurol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Amines; 0 / Analgesics; 0 / Anti-Infective Agents, Urinary; 0 / Cyclohexanecarboxylic Acids; 0 / Thiophenes; 56-12-2 / gamma-Aminobutyric Acid; 6CW7F3G59X / gabapentin; 927AH8112L / Nitrofurantoin; O5TNM5N07U / duloxetine
  •  go-up   go-down


12. |||||||||. 98%  Aracena P, Lazo-Hernández C, Molina-Berríos A, Sepúlveda DR, Reinoso C, Larraín JI, Navarro J, Letelier ME: Microsomal oxidative stress induced by NADPH is inhibited by nitrofurantoin redox biotranformation. Free Radic Res; 2014 Feb;48(2):129-36
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Microsomal oxidative stress induced by NADPH is inhibited by nitrofurantoin redox biotranformation.
  • Nitrofurantoin is used in the antibacterial therapy of the urinary tract.
  • Diverse studies show that the nitro reductive metabolism of nitrofurantoin leads to ROS generation.
  • Oxidative stress arising from this nitro reductive metabolism has been proposed as the mechanism underlying the adverse effects associated with nitrofurantoin.
  • There is, however, an apparent paradox between these findings and the ability of nitrofurantoin to inhibit lipid peroxidation provoked by NADPH in rat liver microsomes.
  • Our results show that microsomal lipid peroxidation promoted by NADPH is inhibited by nitrofurantoin in a concentration-dependent manner.
  • This suggests that the consumption of NADPH in microsomes can be competitively promoted by lipid peroxidation and nitrofurantoin metabolism.
  • The incubation of microsomes with NADPH and nitrofurantoin generated 1-aminohidantoin.
  • In addition, the biotransformation of a classical substrate of CYP450 oxidative system was competitively inhibited by nitrofurantoin.
  • These results suggest that nitrofurantoin is metabolized through CYP450 system.
  • Data are discussed in terms of the in vitro redox metabolism of nitrofurantoin.
  • [MeSH-major] Anti-Infective Agents, Urinary / metabolism. Microsomes, Liver / metabolism. NADP / physiology. Nitrofurantoin / metabolism. Oxidative Stress

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23967899.001).
  • [ISSN] 1029-2470
  • [Journal-full-title] Free radical research
  • [ISO-abbreviation] Free Radic. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / 1-aminohydantoin; 0 / Anti-Infective Agents, Urinary; 0 / Hydantoins; 53-59-8 / NADP; 9035-51-2 / Cytochrome P-450 Enzyme System; 927AH8112L / Nitrofurantoin
  •  go-up   go-down


13. |||||||||. 93%  Forster CJ, Cohee BM, Wood-Morris RN, Hartzell JD: Nitrofurantoin-induced systemic inflammatory response syndrome. Am J Med Sci; 2009 Oct;338(4):338-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nitrofurantoin-induced systemic inflammatory response syndrome.
  • Nitrofurantoin is a commonly used antibiotic for the prophylaxis and treatment of urinary tract infections.
  • We report the first case of nitrofurantoin-induced systemic inflammatory response syndrome, an important adverse drug reaction in the setting of what was initially believed to be a recurrent infection.
  • [MeSH-major] Gram-Negative Bacterial Infections / drug therapy. Nitrofurantoin / adverse effects. Stenotrophomonas / isolation & purification. Systemic Inflammatory Response Syndrome / chemically induced

  • HSDB. structure - NITROFURANTOIN.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19726971.001).
  • [ISSN] 1538-2990
  • [Journal-full-title] The American journal of the medical sciences
  • [ISO-abbreviation] Am. J. Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 927AH8112L / Nitrofurantoin
  •  go-up   go-down


14. |||||||||. 92%  Stock I: [Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections]. Med Monatsschr Pharm; 2014 Jul;37(7):242-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].
  • [Transliterated title] Nitrofurantoin-- Stellenwert bei unkomplizierten Harnwegsinfektionen.
  • The nitrofuran derivative nitrofurantoin has been used for more than 60 years for the antibacterial therapy of uncomplicated urinary tract infections (UTI).
  • Nitrofurantoin therapy has been shown to be accompanied by numerous adverse drug effects.
  • Recent studies, however, have shown a good efficacy and tolerability of short-term nitrofurantoin therapy comparable to previous established standard therapeutic regimens applying cotrimoxazole or quinolones.
  • In many current treatment guidelines, e. g., the international clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women published by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases, nitrofurantoin has been recommended as one first-line antibiotic of empiric antibacterial treatment of uncomplicated cystitis in otherwise healthy women.
  • In Germany, however, nitrofurantoin should only be applied if more effective and less risky antibiotics cannot be used.
  • Nitrofurantoin is contraindicated in the last three months of pregnancy and in patients suffering from renal impairment of each degree.
  • Despite compatibility concerns, nitrofurantoin has also been recommended for the re-infection prophylaxis of recurrent uncomplicated urinary tract infections in Germany and several other countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 25065160.001).
  • [ISSN] 0342-9601
  • [Journal-full-title] Medizinische Monatsschrift für Pharmazeuten
  • [ISO-abbreviation] Med Monatsschr Pharm
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


15. |||||||||. 91%  Jain R, Dwivedi A, Mishra R: Stripping voltammetric behaviour of toxic drug nitrofurantoin. J Hazard Mater; 2009 Sep 30;169(1-3):667-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Stripping voltammetric behaviour of toxic drug nitrofurantoin.
  • A simple, sensitive and reproducible squarewave cathodic adsorptive stripping voltammetric method has been developed for the determination of nitrofurantoin in solubilized system.
  • The objective of the present paper is to investigate the redox behaviour of nitrofurantoin by using different voltammetric techniques and to establish the methodology for its determination in the presence of surfactants.
  • The proposed SWCAdSV voltammetric method allows the determination of nitrofurantoin in linear concentration range 2 x 10(-5) to 1 x 10(-7) mol L(-1).
  • [MeSH-major] Electrochemical Techniques. Nitrofurantoin / chemistry

  • HSDB. structure - TRIMETHYLHEXADECYLAMMONIUM CHLORIDE.
  • HSDB. structure - NITROFURANTOIN.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19409697.001).
  • [ISSN] 1873-3336
  • [Journal-full-title] Journal of hazardous materials
  • [ISO-abbreviation] J. Hazard. Mater.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 0 / Cetrimonium Compounds; 0 / Surface-Active Agents; 927AH8112L / Nitrofurantoin; Z7FF1XKL7A / cetrimonium
  •  go-up   go-down


16. |||||||||. 91%  Broes MJ, Roelofs BF, Mudde AH, Hoornenborg E: [Pulmonary toxicity resulting from the use of nitrofurantoin]. Ned Tijdschr Geneeskd; 2012;156(44):A4990
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pulmonary toxicity resulting from the use of nitrofurantoin].
  • Acute pulmonary syndrome is an uncommon but severe adverse reaction to nitrofurantoin.
  • This syndrome is seldom recognised at the moment of presentation, which potentially subjects patients to unnecessary treatment and delays in the discontinuation of nitrofurantoin.
  • We discuss the case histories of an 80-year-old and an 81-year-old woman, each presenting with acute pulmonary syndrome after nitrofurantoin administration.
  • The diagnosis of acute pulmonary syndrome should be considered in patients presenting with fever, dyspnoea, dry cough, leukocytosis (typically with eosinophilia) and a bilateral interstitial pattern visible on the chest X-ray after having started nitrofurantoin.
  • The prognosis is excellent if the condition is recognised early and the exposure to nitrofurantoin is discontinued.
  • [MeSH-major] Anti-Infective Agents, Urinary / adverse effects. Lung Diseases / chemically induced. Lung Diseases / diagnosis. Nitrofurantoin / adverse effects

  • MedlinePlus Health Information. consumer health - Lung Diseases.
  • HSDB. structure - NITROFURANTOIN.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23114172.001).
  • [ISSN] 1876-8784
  • [Journal-full-title] Nederlands tijdschrift voor geneeskunde
  • [ISO-abbreviation] Ned Tijdschr Geneeskd
  • [Language] dut
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 927AH8112L / Nitrofurantoin
  •  go-up   go-down


17. ||||||||.. 85%  Amábile-Cuevas CF, Arredondo-García JL: Nitrofurantoin, phenazopyridine, and the superoxide-response regulon soxRS of Escherichia coli. J Infect Chemother; 2013 Dec;19(6):1135-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nitrofurantoin, phenazopyridine, and the superoxide-response regulon soxRS of Escherichia coli.
  • Nitrofurantoin and phenazopyridine are two drugs commonly used against urinary tract infections.
  • This study was done to assess the interactions of these drugs with the soxRS regulon of Escherichia coli, a superoxide-defense system (that includes a nitroreductase that yields the active metabolite of nitrofurantoin) involved in antibiotic multi-resistance.
  • The effects of either nitrofurantoin or phenazopyridine, upon strains with different soxRS genotypes, were measured as minimum inhibitory concentrations (MICs) and growth curves.
  • A strain constitutively expressing the soxRS regulon was slightly more susceptible to nitrofurantoin, and more resistant to phenazopyridine, compared to wild-type and soxRS-deleted strains, during early treatment, but 24-h MICs were the same (8 mg/l nitrofurantoin, 1,000 mg/l phenazopyridine) for all strains.
  • Subinhibitory concentrations of phenazopyridine increased the antimicrobial effect of ampicillin, chloramphenicol, tetracycline, and nitrofurantoin.
  • The induction or constitutive expression of the soxRS regulon seems to be a disadvantage for E. coli during nitrofurantoin exposure; but might be an advantage during phenazopyridine exposure, indicating that the latter compound could act as a selective pressure for mutations related to virulence and antibiotic multi-resistance.

  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23793794.001).
  • [ISSN] 1437-7780
  • [Journal-full-title] Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
  • [ISO-abbreviation] J. Infect. Chemother.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


18. ||||||||.. 77%  Tutughamiarso M, Bolte M, Wagner G, Egert E: Five pseudopolymorphs and a cocrystal of nitrofurantoin. Acta Crystallogr C; 2011 Jan;67(Pt 1):o18-25
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Five pseudopolymorphs and a cocrystal of nitrofurantoin.
  • The antibiotic nitrofurantoin {systematic name: (E)-1-[(5-nitro-2-furyl)methylideneamino]imidazolidine-2,4-dione} is not only used for the treatment of urinary tract infections, but also illegally applied as an animal food additive.
  • Since derivatives of 2,6-diaminopyridine might serve as artificial receptors for its recognition, we crystallized one potential drug-receptor complex, nitrofurantoin-2,6-diacetamidopyridine (1/1), C(8)H(6)N(4)O(5)·C(9)H(11)N(3)O(2), (I·II).
  • During the crystallization screening, several new pseudopolymorphs of both components were obtained, namely a nitrofurantoin dimethyl sulfoxide monosolvate, C(8)H(6)N(4)O(5)·C(2)H(6)OS, (Ia), a nitrofurantoin dimethyl sulfoxide hemisolvate, C(8)H(6)N(4)O(5)·0.5C(2)H(6)OS, (Ib), two nitrofurantoin dimethylacetamide monosolvates, C(8)H(6)N(4)O(5)·C(4)H(9)NO, (Ic) and (Id), and a nitrofurantoin dimethylacetamide disolvate, C(8)H(6)N(4)O(5)·2C(4)H(9)NO, (Ie), as well as a 2,6-diacetamidopyridine dimethylformamide monosolvate, C(9)H(11)N(3)O(2)·C(3)H(7)NO, (IIa).
  • Obviously nitrofurantoin prefers the higher-energy conformation in the crystal structures, which all exhibit N-H···O and C-H···O hydrogen-bond interactions.
  • [MeSH-major] Nitrofurantoin / chemistry

  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21206078.001).
  • [ISSN] 1600-5759
  • [Journal-full-title] Acta crystallographica. Section C, Crystal structure communications
  • [ISO-abbreviation] Acta Crystallogr C
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 927AH8112L / Nitrofurantoin
  •  go-up   go-down


19. ||||||||.. 76%  Patel DS, Sharma N, Patel MC, Patel BN, Shrivastav PS, Sanyal M: Quantitation of nitrofurantoin in human plasma by liquid chromatography tandem mass spectrometry. Acta Pharm; 2013 Jun;63(2):141-58
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Quantitation of nitrofurantoin in human plasma by liquid chromatography tandem mass spectrometry.
  • A reliable, selective and sensitive LC-MS/MS assay has been proposed for the determination of nitrofurantoin in human plasma.
  • Quantitation was done using the multiple reaction monitoring (MRM) mode for deprotonated precursor to product ion transitions of nitrofurantoin (m/z 237.0 → 151.8) and nitrofurazone (m/z 197.0 → 123.9).
  • The limit of detection and the lowest limit of quantitation of the method were 0.25 ng mL-1 and 5.00 ng mL-1, respectively, with a linear dynamic range of 5.00-1500 ng mL-1 for nitrofurantoin.
  • The method was successfully applied to a bioequivalence study of a 100 mg nitrofurantoin capsule formulation in 36 healthy subjects.
  • [MeSH-major] Chromatography, Liquid / methods. Nitrofurantoin. Nitrofurazone. Tandem Mass Spectrometry / methods

  • HSDB. structure - NITROFURAZONE.
  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23846139.001).
  • [ISSN] 1846-9558
  • [Journal-full-title] Acta pharmaceutica (Zagreb, Croatia)
  • [ISO-abbreviation] Acta Pharm
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Croatia
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 0 / Capsules; 927AH8112L / Nitrofurantoin; X8XI70B5Z6 / Nitrofurazone
  •  go-up   go-down


20. |||||||... 75%  Nordeng H, Lupattelli A, Romøren M, Koren G: Neonatal outcomes after gestational exposure to nitrofurantoin. Obstet Gynecol; 2013 Feb;121(2 Pt 1):306-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neonatal outcomes after gestational exposure to nitrofurantoin.
  • OBJECTIVE: To estimate whether first-trimester exposure to nitrofurantoin is associated with increased malformation rates and, secondarily, to estimate whether exposure to nitrofurantoin is associated with increased rates of negative pregnancy outcomes and perinatal complications.
  • The pregnancy outcomes of women who were dispensed nitrofurantoin during pregnancy were compared with the outcomes of women who were dispensed pivmecillinam (disease comparison group) and unexposed women.
  • RESULTS: In all, 5,794 (3.2%) filled prescriptions for nitrofurantoin during pregnancy, 1,334 women (0.7%) in the first trimester and 979 women (0.5%) in the last 4 weeks of pregnancy.
  • Dispensing nitrofurantoin during the first trimester was not associated with increased risk of major malformations (31 of 1,334 [2.3%]) compared with disease controls (162 of 5,800 [2.8%], odds ratio [OR] 0.79, 95% confidence interval [CI] 0.51-1.23).
  • Dispensing nitrofurantoin the last 30 days before delivery was associated with increased risk of neonatal jaundice (103 of 959 [10.8%]) compared with unexposed women (10,336 of 127,507 [8.1%], OR 1.31, 95% CI 1.02-1.70).
  • CONCLUSION: The results from this large, population-based study suggest that the teratogenic potential of nitrofurantoin is low.
  • [MeSH-major] Abnormalities, Drug-Induced / etiology. Anti-Infective Agents, Urinary / adverse effects. Infant, Newborn, Diseases / chemically induced. Nitrofurantoin / adverse effects. Prenatal Exposure Delayed Effects / chemically induced


21. |||||||... 74%  Goldberg O, Koren G, Landau D, Lunenfeld E, Matok I, Levy A: Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations. J Clin Pharmacol; 2013 Sep;53(9):991-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations.
  • Antibacterial drugs are among the most common medications used by pregnant women.
  • While medical literature generally defines nitrofurantoin as an antibiotic that is safe for use during the first trimester of pregnancy, new concerns about a possible association between congenital malformations following exposure to nitrofurantoin during the first trimester of pregnancy have recently surfaced.
  • Associations between exposure to nitrofurantoin during the first trimester and major malformations were assessed.
  • A total of 1,329 infants and abortuses had been exposed to nitrofurantoin during the first trimester of pregnancy.
  • Exposure to nitrofurantoin was not associated with increased risk of major malformations in general (adjusted OR = 0.85, 95% CI 0.67-1.08) or with specific malformations.
  • First trimester exposure to nitrofurantoin was not associated with increased risk for total major congenital malformations or with specific malformations.
  • [MeSH-major] Abnormalities, Drug-Induced / epidemiology. Anti-Infective Agents, Urinary / therapeutic use. Maternal-Fetal Exchange. Nitrofurantoin / therapeutic use. Urinary Tract Infections / drug therapy

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Pregnancy and Medicines.
  • MedlinePlus Health Information. consumer health - Urinary Tract Infections.
  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © The Author(s) 2013.
  • (PMID = 23873250.001).
  • [ISSN] 1552-4604
  • [Journal-full-title] Journal of clinical pharmacology
  • [ISO-abbreviation] J Clin Pharmacol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 927AH8112L / Nitrofurantoin
  • [Keywords] NOTNLM ; congenital malformations / nitrofurantoin / pregnancy
  •  go-up   go-down


22. |||||||... 73%  Sakaan SA, Twilla JD, Usery JB, Winton JC, Self TH: Nitrofurantoin-induced hepatotoxicity: a rare yet serious complication. South Med J; 2014 Feb;107(2):107-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nitrofurantoin-induced hepatotoxicity: a rare yet serious complication.
  • Nitrofurantoin is a commonly prescribed antibiotic for the treatment of recurrent uncomplicated urinary tract infections.
  • Since its introduction into clinical practice, nitrofurantoin has been associated with various adverse effects, including hepatotoxicity.
  • Key search terms included "nitrofurantoin AND hepatotoxicity" as well as "nitrofurantoin AND hepatitis."
  • A broad spectrum of liver toxicity associated with nitrofurantoin use has been reported, ranging from acute hepatitis, granulomatous reaction, cholestasis, or autoimmune-mediated hepatitis to chronic active hepatitis that could lead to cirrhosis or death.
  • It has been postulated that prolonged exposure to nitrofurantoin, female sex, advanced age, and reduced renal function increase the risk of developing hepatotoxicity.
  • For the management of severe cases, corticosteroids have been used along with nitrofurantoin discontinuation.
  • Given the severity and seriousness of the adverse effect of hepatotoxicity, clinicians should weigh the risks and benefits of nitrofurantoin before initiating therapy, especially in long-term prophylaxis in high-risk patients.
  • Clinicians also should be well versed in recognizing and managing liver injury associated with nitrofurantoin.
  • [MeSH-major] Anti-Infective Agents, Urinary / adverse effects. Drug-Induced Liver Injury. Liver / drug effects. Nitrofurantoin / adverse effects. Urinary Tract Infections / drug therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24926677.001).
  • [ISSN] 1541-8243
  • [Journal-full-title] Southern medical journal
  • [ISO-abbreviation] South. Med. J.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 927AH8112L / Nitrofurantoin
  •  go-up   go-down


23. |||||||... 73%  Milić R, Plavec G, Tufegdzić I, Tomić I, Sarac S, Loncarević O: Nitrofurantoin-induced immune-mediated lung and liver disease. Vojnosanit Pregl; 2012 Jun;69(6):536-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nitrofurantoin-induced immune-mediated lung and liver disease.
  • INTRODUCTION: Nitrofurantoin, a furan derivative, introduced in the fifties has widely been used as an effective agent for the treatment and prevention of urinary tract infections (UTI).
  • Spectrum of adverse reactions to nitrofurantoin is wide, ranging from eosinophilic interstitial lung disease, acute hepatitis and granulomatous reaction, to the chronic active hepatitis, a very rare adverse effect, that can lead to cirrhosis and death.
  • CASE REPORT: We presented a 55-year- old female patient with eosinophilic interstitial lung disease, severe chronic active hepatitis and several other immune- mediated multisystemic manifestations of prolonged exposure to nitrofurantoin because of the recurrent UTI caused by Escherichia coli.
  • After withdrawal of nitrofurantoin and application of high dose of glicocorticosteroids, prompt clinical and laboratory recovery was achieved.
  • Consideration should be given to monitor lung and liver function tests during long term nitrofurantoin therapy.
  • [MeSH-major] Anti-Infective Agents, Urinary / adverse effects. Autoimmune Diseases / chemically induced. Drug-Induced Liver Injury / etiology. Lung Diseases / chemically induced. Nitrofurantoin / adverse effects


24. |||||||... 72%  Aksamija A, Horvat G, Habek D, Zalac D, Jendris E: Nitrofurantoin-induced acute liver damage in pregnancy. Arh Hig Rada Toksikol; 2009 Sep;60(3):357-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nitrofurantoin-induced acute liver damage in pregnancy.
  • In the 36th week of gestation, the patient was introduced nitrofurantoin 100 mg a day due to symptoms of dysuria and enterococcus isolated from urine culture.
  • Nitrofurantoin therapy was discontinued.
  • Given that discontinuation of nitrofurantoin and introduction of methylprednisolon therapy significantly lowered liver enzyme levels, restoring most of them to normal, we concluded that this was probably the case of toxic liver damage caused by nitrofurantoin.
  • [MeSH-major] Anti-Infective Agents, Urinary / adverse effects. Drug-Induced Liver Injury / etiology. Nitrofurantoin / adverse effects. Pregnancy Complications / chemically induced

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Health Problems in Pregnancy.
  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19789166.001).
  • [ISSN] 0004-1254
  • [Journal-full-title] Arhiv za higijenu rada i toksikologiju
  • [ISO-abbreviation] Arh Hig Rada Toksikol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Croatia
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 927AH8112L / Nitrofurantoin
  •  go-up   go-down


25. |||||||... 71%  Athikomrattanakul U, Katterle M, Gajovic-Eichelmann N, Scheller FW: Development of molecularly imprinted polymers for the binding of nitrofurantoin. Biosens Bioelectron; 2009 Sep 15;25(1):82-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Development of molecularly imprinted polymers for the binding of nitrofurantoin.
  • Novel molecularly imprinted polymers (MIPs) for the recognition of nitrofurantoin (NFT) were prepared by photoinitiated polymerisation in polar solvent using 2,6-bis(methacrylamido) pyridine (BMP) as the functional monomer and carboxyphenyl aminohydantoin (CPAH) as the analogue of the template.
  • The binding constants of the complex between BMP and nitrofurantoin or CPAH in DMSO were determined with 1H NMR titration to be 630+/-104 and 830+/-146 M(-1), respectively.
  • The imprinting factor at saturation concentration of nitrofurantoin, which is the ratio of the amount bound to the MIP and the non-imprinted control polymer (NIP), was determined to be 2.47 for MIP1 and 2.49 for MIP2.
  • [MeSH-major] Acrylamides / chemistry. Molecular Imprinting / methods. Nitrofurantoin / analysis. Polymers / chemistry. Pyridines / chemistry

  • HSDB. structure - NITROFURANTOIN.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19559593.001).
  • [ISSN] 1873-4235
  • [Journal-full-title] Biosensors & bioelectronics
  • [ISO-abbreviation] Biosens Bioelectron
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Acrylamides; 0 / Polymers; 0 / Pyridines; 927AH8112L / Nitrofurantoin; K67NG89J77 / methacrylamide
  •  go-up   go-down


26. |||||||... 69%  Cherukuvada S, Babu NJ, Nangia A: Nitrofurantoin-p-aminobenzoic acid cocrystal: hydration stability and dissolution rate studies. J Pharm Sci; 2011 Aug;100(8):3233-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nitrofurantoin-p-aminobenzoic acid cocrystal: hydration stability and dissolution rate studies.
  • Nitrofurantoin (NF) drug is known to transform to a hydrate form in aqueous medium.
  • [MeSH-major] 4-Aminobenzoic Acid / chemistry. Anti-Infective Agents, Urinary / chemistry. Nitrofurantoin / chemistry

  • HSDB. structure - 4-AMINOBENZOIC ACID.
  • HSDB. structure - UREA.
  • HSDB. structure - NITROFURANTOIN.
  • HSDB. structure - (L)-ARGININE.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2011 Wiley-Liss, Inc.
  • (PMID = 21425165.001).
  • [ISSN] 1520-6017
  • [Journal-full-title] Journal of pharmaceutical sciences
  • [ISO-abbreviation] J Pharm Sci
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 059QF0KO0R / Water; 8W8T17847W / Urea; 927AH8112L / Nitrofurantoin; 94ZLA3W45F / Arginine; TL2TJE8QTX / 4-Aminobenzoic Acid
  •  go-up   go-down


27. |||||||... 69%  American College of Obstetricians and Gynecologists Committee on Obstetric Practice: ACOG Committee Opinion No. 494: Sulfonamides, nitrofurantoin, and risk of birth defects. Obstet Gynecol; 2011 Jun;117(6):1484-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] ACOG Committee Opinion No. 494: Sulfonamides, nitrofurantoin, and risk of birth defects.
  • Prescribing sulfonamides or nitrofurantoin in the first trimester is still considered appropriate when no other suitable alternative antibiotics are available.
  • [MeSH-major] Abnormalities, Drug-Induced. Anti-Infective Agents, Urinary / adverse effects. Nitrofurantoin / adverse effects. Sulfonamides / adverse effects

  • Genetic Alliance. consumer health - Birth Defects.
  • MedlinePlus Health Information. consumer health - Pregnancy and Medicines.
  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21606771.001).
  • [ISSN] 1873-233X
  • [Journal-full-title] Obstetrics and gynecology
  • [ISO-abbreviation] Obstet Gynecol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 0 / Sulfonamides; 927AH8112L / Nitrofurantoin
  •  go-up   go-down


28. |||||||... 69%  Kang XS, Hou DB, Zhang GX, Chen XA, Yue FH, Huang PJ, Zhou ZK: [Spectral analysis of nitrofurantoin in the terahertz frequency range]. Guang Pu Xue Yu Guang Pu Fen Xi; 2012 Jul;32(7):1744-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Spectral analysis of nitrofurantoin in the terahertz frequency range].
  • The present article measured the absorption coefficient spectra and refractive index spectra of nitrofurantoin original drug, which is one kind of nitrofuran drugs, in the terahertz frequency range from 0.2 to 1.8 THz using terahertz time-domain spectroscopy.
  • The results showed that there exist a number of characteristic absorption peaks of nitrofurantoin with different intensity in the range and the absorption coefficient spectra can be used to identify nitrofurantoin.
  • The article also simulated absorption coefficient spectra of nitrofurantoin molecule within 0.2 - 1.8 THz using density functional theory by Gaussian software, and vibrational modes of some peaks in the experimental absorption coefficient spectra were analyzed and identified.
  • The results show that the experimental absorption peaks at 1.25 and 1.60 THz correspond with the theoretical peaks at 1.30 and 1.67 THz, and these experimental peaks were caused by intramolecular vibrational modes of nitrofurantoin.

  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23016316.001).
  • [ISSN] 1000-0593
  • [Journal-full-title] Guang pu xue yu guang pu fen xi = Guang pu
  • [ISO-abbreviation] Guang Pu Xue Yu Guang Pu Fen Xi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


29. |||||||... 68%  Al-Zarouni M, Senok A, Al-Zarooni N, Al-Nassay F, Panigrahi D: Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline. Med Princ Pract; 2012;21(6):543-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.
  • OBJECTIVE: To assess the susceptibility trends of community-acquired extended-spectrum β-Iactamase (ESBL)-producing urinary isolates with particular reference to fosfomycin, nitrofurantoin and tigecycline.
  • The antibiotic sensitivity of ESBL-producing uropathogens to a panel of antibiotics including tigecycline, fosfomycin and nitrofurantoin was assessed.
  • Sensitivity to nitrofurantoin and fosfomycin was 90 and 100%, respectively.
  • Fosfomycin and nitrofurantoin were active against ESBL-positive uropathogens, and emergence of tigecycline resistance needs close monitoring.
  • [MeSH-minor] Chi-Square Distribution. Fosfomycin / pharmacology. Fosfomycin / therapeutic use. Genotype. Humans. Minocycline / analogs & derivatives. Minocycline / pharmacology. Minocycline / therapeutic use. Nitrofurantoin / pharmacology. Nitrofurantoin / therapeutic use. United Arab Emirates

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • MedlinePlus Health Information. consumer health - Urinary Tract Infections.
  • HSDB. structure - MINOCYCLINE.
  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2012 S. Karger AG, Basel.
  • (PMID = 22722224.001).
  • [ISSN] 1423-0151
  • [Journal-full-title] Medical principles and practice : international journal of the Kuwait University, Health Science Centre
  • [ISO-abbreviation] Med Princ Pract
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Anti-Infective Agents, Urinary; 0 / tigecycline; 2N81MY12TE / Fosfomycin; 927AH8112L / Nitrofurantoin; FYY3R43WGO / Minocycline
  •  go-up   go-down


30. |||||||... 68%  Koradia V, de Diego HL, Elema MR, Rantanen J: Integrated approach to study the dehydration kinetics of nitrofurantoin monohydrate. J Pharm Sci; 2010 Sep;99(9):3966-76
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Integrated approach to study the dehydration kinetics of nitrofurantoin monohydrate.
  • The present study was aimed at gaining a mechanistic understanding of the dehydration of nitrofurantoin monohydrate II (NF-MH).
  • [MeSH-major] Anti-Infective Agents, Urinary / chemistry. Nitrofurantoin / chemistry. Water / chemistry

  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20575054.001).
  • [ISSN] 1520-6017
  • [Journal-full-title] Journal of pharmaceutical sciences
  • [ISO-abbreviation] J Pharm Sci
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 059QF0KO0R / Water; 927AH8112L / Nitrofurantoin
  •  go-up   go-down


31. |||||||... 67%  de Lima-Neto P, Correia AN, Portela RR, Julião Mda S, Linhares-Junior GF, de Lima JE: Square wave voltammetric determination of nitrofurantoin in pharmaceutical formulations on highly boron-doped diamond electrodes at different boron-doping contents. Talanta; 2010 Mar 15;80(5):1730-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Square wave voltammetric determination of nitrofurantoin in pharmaceutical formulations on highly boron-doped diamond electrodes at different boron-doping contents.
  • The influence of the boron-doping levels in boron-doped diamond film electrodes on the electrochemical response of nitrofurantoin (NFT) and the development of an electroanalytical procedure for NFT determination were investigated.
  • [MeSH-major] Anti-Infective Agents, Urinary / analysis. Boron / chemistry. Electrochemistry / methods. Nitrofurantoin / analysis

  • HSDB. structure - NITROFURANTOIN.
  • HSDB. structure - BORON.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 Elsevier B.V. All rights reserved.
  • (PMID = 20152404.001).
  • [ISSN] 1873-3573
  • [Journal-full-title] Talanta
  • [ISO-abbreviation] Talanta
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 7782-40-3 / Diamond; 927AH8112L / Nitrofurantoin; N9E3X5056Q / Boron
  •  go-up   go-down


32. |||||||... 67%  Cooper IF, Siadaty MS: 'Pharmacologic Substances or Antibiotics or Clinical Drugs' associated with 'Nitrofurantoin Susceptibility': Top Publications. BioMedLib Review; PharmacologicSubstanceAntibiotic;NitrofurantoinSusceptibility:705457937. ISSN: 2331-5717. 2014/4/30
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Pharmacologic Substances or Antibiotics or Clinical Drugs' associated with 'Nitrofurantoin Susceptibility': Top Publications.
  • Background: There are articles published each month which present 'pharmacologic substance or antibiotic or clinical drug' for 'nitrofurantoin susceptibility'.
  • However these articles are spread across thousands of journals, and there are many types of 'pharmacologic substance or antibiotic or clinical drug'.
  • Karlowsky JA et al: Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
  • Babakir-Mina M et al: Antibiotic susceptibility of vancomyin and nitrofurantoin in Staphylococcus aureus isolated from burnt patients in Sulaimaniyah, Iraqi Kurdistan.
  • Anklesaria P et al: In vitro susceptibility of urinary pathogens to trimethoprim, nitrofurantoin and trimethoprim--nitrofurantoin combination.
  • Patil P et al: In vitro susceptibility of urinary pathogens to trimethoprim, nitrofurantoin and trimethoprim-nitrofuratoin combination.
  • Babakir-Mina M et al: Author response to laboratory detection of MRSA. Comment on "Antibiotic susceptibility of vancomyin and nitrofurantoin in Staphylococcus aureus isolated from burnt patients in Sulaimaniyah, Iraqi Kurdistan".
  • Hoo R et al: Potential unreliability of nitrofurantoin disks in susceptibility testing.
  • Obaseiki-Ebor EE: Enhanced Escherichia coli susceptibility to nitrofurantoin by EDTA and multiple aminoglycoside antibiotics resistance mutation.
  • Jasińska B et al: [Susceptibility to nitrofurantoin, biseptol and nalidixic acid of E. coli strains isolated from urine in the years 1983-1990].
  • Traub WH et al: Nonspecific resistance of Serratia marcescens against antimicrobial drugs. Resistance or decreased susceptibility of phenotypic variants against chloramphenicol, nalidixic acid, nitrofurantoin, sulfonamides and trimethoprim.
  • Al-Zarouni M et al: Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 705457937.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


33. |||||||... 67%  Babakir-Mina M, Othman N, Najmuldeen HH, Noori CK, Fatah CF, Perno CF, Ciotti M: Antibiotic susceptibility of vancomyin and nitrofurantoin in Staphylococcus aureus isolated from burnt patients in Sulaimaniyah, Iraqi Kurdistan. New Microbiol; 2012 Oct;35(4):439-46
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Antibiotic susceptibility of vancomyin and nitrofurantoin in Staphylococcus aureus isolated from burnt patients in Sulaimaniyah, Iraqi Kurdistan.
  • Furthermore there was a significant association between age and antibiotic resistance for all antibiotics except for vancomycin and nitrofurantoin.
  • [MeSH-major] Anti-Bacterial Agents / pharmacology. Burns / microbiology. Nitrofurantoin / pharmacology. Staphylococcal Infections / microbiology. Staphylococcus aureus / drug effects. Vancomycin / pharmacology


34. |||||||... 66%  Maaland M, Guardabassi L: In vitro antimicrobial activity of nitrofurantoin against Escherichia coli and Staphylococcus pseudintermedius isolated from dogs and cats. Vet Microbiol; 2011 Aug 5;151(3-4):396-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] In vitro antimicrobial activity of nitrofurantoin against Escherichia coli and Staphylococcus pseudintermedius isolated from dogs and cats.
  • Minimum inhibitory concentrations (MIC) of nitrofurantoin were determined by agar dilution in 269 canine and feline isolates of Escherichia coli and Staphylococcus pseudintermedius, two of the most common bacterial species associated with urinary tract infection (UTI) in small animals.
  • All isolates, including multidrug-resistant strains of known genetic background, displayed MICs below the drug concentrations reported in canine urine following oral administration of nitrofurantoin.
  • Preliminary data on mutant prevention concentration (MPC) and many years of nitrofurantoin usage in human medicine suggest that emergence of resistant mutants during treatment is not a critical issue for this drug.
  • The study provides species-specific data on nitrofurantoin MIC distribution that can be used for setting dog- and cat-specific breakpoints.
  • Although nitrofurantoin is not an appropriate first-line agent for empirical treatment of canine UTI due to toxicity and poor pharmacokinetic properties, it may be indicated for treatment of UTI caused by multidrug-resistant bacteria, which are otherwise difficult to treat using conventional veterinary antimicrobial agents.
  • [MeSH-major] Anti-Infective Agents / pharmacology. Escherichia coli / drug effects. Nitrofurantoin / pharmacology. Staphylococcus / drug effects

  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2011. Published by Elsevier B.V.
  • (PMID = 21482044.001).
  • [ISSN] 1873-2542
  • [Journal-full-title] Veterinary microbiology
  • [ISO-abbreviation] Vet. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Anti-Infective Agents; 927AH8112L / Nitrofurantoin
  •  go-up   go-down


35. ||||||.... 65%  Mendoza-Valdes A, Rosete A, Rios Bueno E, Frentzel A, Trapp S, Kirch W, Mueller EA: [Antimicrobial and clinical efficacy of nitrofurantoin in the treatment of acute lower urinary tract infections in adults]. Med Klin (Munich); 2010 Oct;105(10):698-704
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Antimicrobial and clinical efficacy of nitrofurantoin in the treatment of acute lower urinary tract infections in adults].
  • [Transliterated title] Antimikrobielle und klinische Wirksamkeit von Nitrofurantoin in der Behandlung akuter Infekte der unteren ableitenden Harnwege bei Erwachsenen.
  • BACKGROUND AND PURPOSE: In the light of increasing resistance to antibiotics used for the treatment of acute urinary tract infections, nitrofurantoin currently experiences a renaissance.
  • Nitrofurantoin shows good efficacy against most bacteria expected in urinary tract infection, and the development of resistance is low.
  • A study on the antimicrobial and clinical efficacy of nitrofurantoin in the treatment of acute lower urinary tract infections was conducted in Mexico City, an area where resistance rates of uropathogens to trimethoprim/sulfamethoxazole (cotrimoxazole) are high.
  • PATIENTS AND METHODS: In this open-label, single-arm study 20 adult patients (18 females, 2 males) with positive urine culture were treated orally with nitrofurantoin sustained release 100 mg twice daily for 7 days.
  • Urinary nitrofurantoin concentrations were determined at baseline and day 4 of the study.
  • Primary endpoint was the antimicrobial efficacy of nitrofurantoin at 12 to 16 days after baseline, assessed by changes in urine culture results.
  • Urinary nitrofurantoin concentrations were mostly above minimum inhibitory concentrations of the isolated uropathogens.
  • CONCLUSION: The results of the present study indicate good antimicrobial and clinical efficacy of nitrofurantoin in the treatment of acute uncomplicated urinary tract infections as well as acceptable tolerability in adults.
  • [MeSH-major] Anti-Infective Agents, Urinary / therapeutic use. Bacteriuria / drug therapy. Nitrofurantoin / therapeutic use. Urinary Tract Infections / drug therapy

  • MedlinePlus Health Information. consumer health - Urinary Tract Infections.
  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20981588.001).
  • [ISSN] 1615-6722
  • [Journal-full-title] Medizinische Klinik (Munich, Germany : 1983)
  • [ISO-abbreviation] Med. Klin. (Munich)
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 0 / Delayed-Action Preparations; 927AH8112L / Nitrofurantoin
  •  go-up   go-down


36. ||||||.... 63%  Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, Woodford N: What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents; 2011 May;37(5):415-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
  • In this study, the activity of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline was evaluated against 81 carbapenem-resistant Enterobacteriaceae isolates from the UK.
  • Chloramphenicol, ciprofloxacin and nitrofurantoin inhibited <25% of the isolates at the breakpoint, whereas colistin was active against 75/81 isolates (92.6%), the exceptions being four Klebsiella pneumoniae and Enterobacter cloacae isolates along with members of inherently resistant genera.

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • ExactAntigen/Labome. author profiles.
  • Faculty of 1000. See the articles recommended by F1000Prime's Faculty of more than 5,000 expert scientists and clinical researchers. (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2011 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
  • (PMID = 21429716.001).
  • [ISSN] 1872-7913
  • [Journal-full-title] International journal of antimicrobial agents
  • [ISO-abbreviation] Int. J. Antimicrob. Agents
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Bacterial Proteins; EC 3.5.2.6 / beta-Lactamases; EC 3.5.2.6 / carbapenemase
  •  go-up   go-down


37. ||||||.... 62%  Sherigar JM, Fazio R, Zuang M, Arsura E: Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease. Clin Pract; 2012 Oct 12;2(4):e83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease.
  • Nitrofurantoin has been in use since 1953 as an effective agent for the prevention of recurrent urinary tract infection.
  • We present a case of nitrofurantoin induced chronic active hepatitis and briefly review the serology and clinico pathological features of 57 similar cases reported in English literature.
  • Complete recovery is possible in most cases if medication is discontinued in time.
  • Steroids may play a role in management if no improvement occurs despite discontinuation of medication.
  • We suggest all patients who are on prolonged nitrofurantoin therapy be followed up with anti nuclear antibody, anti smooth muscle antibody, serum immunoglobulin and hepatic panel every three months.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24765482.001).
  • [ISSN] 2039-7275
  • [Journal-full-title] Clinics and practice
  • [ISO-abbreviation] Clin Pract
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC3981194
  • [Keywords] NOTNLM ; anti nuclear antibody / anti smooth muscle antibody / chronic active hepatitis / hepatotoxicity. / nitrofurantoin
  •  go-up   go-down


38. ||||||.... 61%  Geerts AF, Eppenga WL, Heerdink R, Derijks HJ, Wensing MJ, Egberts TC, De Smet PA: Ineffectiveness and adverse events of nitrofurantoin in women with urinary tract infection and renal impairment in primary care. Eur J Clin Pharmacol; 2013 Sep;69(9):1701-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ineffectiveness and adverse events of nitrofurantoin in women with urinary tract infection and renal impairment in primary care.
  • PURPOSE: To determine whether treatment with nitrofurantoin in women with urinary tract infection (UTI) and renal impairment in primary care is associated with a higher risk of ineffectiveness and/or serious adverse events than in women without renal impairment.
  • METHODS: A cohort of 21,317 women treated with nitrofurantoin and a cohort of 7,926 women treated with trimethoprim, identified from the Pharmo Record Linkage System, were analysed.
  • The primary outcome was ineffectiveness of treatment of nitrofurantoin defined as the start of a second antibacterial within 1 month after the start of nitrofurantoin.
  • The secondary outcome was the occurrence of serious adverse events of nitrofurantoin leading to hospitalization within 90 days.
  • A cohort of trimethoprim users was used to determine if the associations found for nitrofurantoin were mainly related to nitrofurantoin itself.
  • In patients with renal impairment (<50 ml/min/1.73 m²) the risk of pulmonary adverse events leading to hospitalization was significantly increased (HR 4.1, 95 % CI 1.31-13.09) CONCLUSIONS: Nitrofurantoin treatment was not associated with a higher risk of ineffectiveness in women with UTI and moderate renal impairment (30-50 ml/min/1.73 m²).
  • [MeSH-major] Anti-Infective Agents, Urinary / adverse effects. Nitrofurantoin / adverse effects. Renal Insufficiency / drug therapy. Urinary Tract Infections / drug therapy


39. ||||||.... 61%  Athikomrattanakul U, Gajovic-Eichelmann N, Scheller FW: Thermometric sensing of nitrofurantoin by noncovalently imprinted polymers containing two complementary functional monomers. Anal Chem; 2011 Oct 15;83(20):7704-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Thermometric sensing of nitrofurantoin by noncovalently imprinted polymers containing two complementary functional monomers.
  • Molecularly imprinted polymers (MIPs) for nitrofurantoin (NFT) recognition addressing in parallel of two complementary functional groups were created using a noncovalent imprinting approach.
  • Specific tailor-made functional monomers were synthesized: a diaminopyridine derivative as the receptor for the imide residue and three (thio)urea derivatives for the interaction with the nitro group of NFT.
  • A significantly improved binding of NFT to the new MIPs was revealed from the imprinting factor, efficiency of binding, affinity constants and maximum binding number as compared to previously reported MIPs, which addressed either the imide or the nitro residue.
  • Substances possessing only one functionality (either the imide group or nitro group) showed significantly weaker binding to the new imprinted polymers than NFT.
  • [MeSH-major] Molecular Imprinting. Nitrofurantoin / analysis. Polymers / chemistry. Temperature

  • HSDB. structure - PYRIDINE.
  • HSDB. structure - UREA.
  • HSDB. structure - NITROFURANTOIN.
  • HSDB. structure - DIMETHYL SULFOXIDE.
  • HSDB. structure - ACETONITRILE.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2011 American Chemical Society
  • (PMID = 21958006.001).
  • [ISSN] 1520-6882
  • [Journal-full-title] Analytical chemistry
  • [ISO-abbreviation] Anal. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Acetonitriles; 0 / Imides; 0 / Polymers; 0 / Pyridines; 8W8T17847W / Urea; 927AH8112L / Nitrofurantoin; NH9L3PP67S / pyridine; YOW8V9698H / Dimethyl Sulfoxide; Z072SB282N / acetonitrile
  •  go-up   go-down


40. ||||||.... 59%  Sargın G, Elbek O, Balantekin C, Meteoglu I, Culhacı N: Acute respiratory distress syndrome and hepatotoxicity associated with single dose nitrofurantoin use. Case Rep Pulmonol; 2012;2012:465389
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acute respiratory distress syndrome and hepatotoxicity associated with single dose nitrofurantoin use.
  • Nitrofurantoin is a synthetic nitrofuran compound.
  • A number of adverse effects may develop in different body systems during nitrofurantoin treatment; however, concomitant pulmonary and hepatotoxicity are rare.
  • In this paper, we present a case of acute respiratory distress syndrome and hepatotoxicity following administration of a single dose of nitrofurantoin.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Pharmacother. 2004 Apr;38(4):612-6 [14966256.001]
  • [Cites] Ann Hepatol. 2007 Apr-Jun;6(2):119-21 [17519837.001]
  • [Cites] Arh Hig Rada Toksikol. 2009 Sep;60(3):357-61 [19789166.001]
  • [Cites] Am J Gastroenterol. 1992 Jul;87(7):891-3 [1615946.001]
  • [Cites] Eur J Respir Dis. 1981 Jun;62(3):180-9 [7308333.001]
  • [Cites] Am J Gastroenterol. 1998 May;93(5):819-21 [9625135.001]
  • [Cites] Am J Med Sci. 1999 May;317(5):336-40 [10334121.001]
  • [Cites] J Comput Assist Tomogr. 2000 Mar-Apr;24(2):259-61 [10752888.001]
  • [Cites] CMAJ. 2007 Jan 30;176(3):319-20 [17261825.001]
  • [Cites] J Med Case Rep. 2007;1:59 [17678542.001]
  • [Cites] J Med Case Rep. 2010;4:311 [20863377.001]
  • [Cites] Am J Med. 1980 Nov;69(5):733-8 [7435512.001]
  • (PMID = 23227407.001).
  • [ISSN] 2090-6854
  • [Journal-full-title] Case reports in pulmonology
  • [ISO-abbreviation] Case Rep Pulmonol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3514810
  •  go-up   go-down


41. ||||||.... 59%  Kawase A, Matsumoto Y, Hadano M, Ishii Y, Iwaki M: Differential effects of chrysin on nitrofurantoin pharmacokinetics mediated by intestinal breast cancer resistance protein in rats and mice. J Pharm Pharm Sci; 2009;12(2):150-63
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differential effects of chrysin on nitrofurantoin pharmacokinetics mediated by intestinal breast cancer resistance protein in rats and mice.
  • We examined the pharmacokinetics of nitrofurantoin, a specific Bcrp substrate, in rats and mice treated with chrysin.
  • RESULTS: Plasma concentrations of nitrofurantoin were increased in rats, but not mice, treated with oral chrysin, compared with untreated controls.
  • Intraperitoneal injection of chrysin into rats or mice had little effect on the elimination of nitrofurantoin, compared with untreated animals.
  • CONCLUSIONS: These results suggest that chrysin-nitrofurantoin interactions occur in the small intestine in rats, but not in mice, possibly due to the higher levels of Bcrp expression in the small intestine in rats, compared with those in mice.
  • [MeSH-major] ATP-Binding Cassette Transporters / metabolism. Flavonoids / pharmacology. Nitrofurantoin / pharmacokinetics

  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19732493.001).
  • [ISSN] 1482-1826
  • [Journal-full-title] Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques
  • [ISO-abbreviation] J Pharm Pharm Sci
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Abcg2 protein, mouse; 0 / Abcg2 protein, rat; 0 / Anti-Infective Agents, Urinary; 0 / Antioxidants; 0 / Flavonoids; 0 / RNA, Messenger; 3CN01F5ZJ5 / chrysin; 927AH8112L / Nitrofurantoin
  •  go-up   go-down


42. ||||||.... 59%  Appleyard S, Saraswati R, Gorard DA: Autoimmune hepatitis triggered by nitrofurantoin: a case series. J Med Case Rep; 2010;4:311
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Autoimmune hepatitis triggered by nitrofurantoin: a case series.
  • CASE PRESENTATION: Three Caucasian women (aged 65, 42 and 74 years old) who were receiving long-term nitrofurantoin as prophylaxis against recurrent urinary tract infections developed hepatitic liver disease.
  • In all three patients nitrofurantoin was withdrawn, and long-term immunosuppressive therapy with prednisolone and azathioprine or mycophenolate was given.
  • CONCLUSIONS: Although nitrofurantoin rarely causes autoimmune hepatitis, this antimicrobial is increasingly used as long-term prophylaxis against recurrent urinary tract infection.
  • General practitioners and urologists who prescribe long-term nitrofurantoin therapy should be aware of this adverse effect.

  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20863377.001).
  • [ISSN] 1752-1947
  • [Journal-full-title] Journal of medical case reports
  • [ISO-abbreviation] J Med Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2955056
  •  go-up   go-down


43. ||||||.... 59%  Oplinger M, Andrews CO: Nitrofurantoin contraindication in patients with a creatinine clearance below 60 mL/min: looking for the evidence. Ann Pharmacother; 2013 Jan;47(1):106-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nitrofurantoin contraindication in patients with a creatinine clearance below 60 mL/min: looking for the evidence.
  • OBJECTIVE: To investigate the evidence leading to nitrofurantoin contraindication in patients with a creatinine clearance (CrCl) below 60 mL/min.
  • DATA SOURCES: Literature was searched in PubMed (1965-June 2012) by using the key words and MeSH terms urinary tract infections-drug therapy, chronic kidney insufficiency, kidney diseases, pharmacokinetics, safety, and efficacy, combined with nitrofurantoin.
  • References from the identified studies, Food and Drug Administration-approved product information packets, drug information resources, and pharmacology books were also reviewed.
  • DATA SYNTHESIS: The contraindication of nitrofurantoin in patients with a CrCl below 60 mL/min was included in the product information packets sometime between 1988 and 2003.
  • The 1988 Macrodantin product information indicated a CrCl cutoff level of 40 mL/min, but the current contraindication of less than 60 mL/min is found in the 2003 Macrobid product information.
  • This and previous studies have several and severe limitations, such as the inclusion of a small number of patients, an undefined or poorly defined method to determine CrCl and renal impairment, measurement of amounts of nitrofurantoin excreted in the urine instead of urinary concentrations, and most importantly, a lack of clinical efficacy end points.
  • More recently, a chart review on clinical cure of urinary tract infections treated with nitrofurantoin provided grounds for further investigations on the utility of this drug for patients with a CrCl of 60 mL/min or lower.
  • Concerns of increased risks of serious adverse reactions in patients with reduced renal function have further limited the use of nitrofurantoin.
  • CONCLUSIONS: Data supporting the contraindication of nitrofurantoin for patients with a CrCl less than 60 mL/min are nonexistent.
  • [MeSH-major] Anti-Infective Agents, Urinary / contraindications. Kidney Diseases / physiopathology. Nitrofurantoin / contraindications

  • MedlinePlus Health Information. consumer health - Kidney Diseases.
  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23341159.001).
  • [ISSN] 1542-6270
  • [Journal-full-title] The Annals of pharmacotherapy
  • [ISO-abbreviation] Ann Pharmacother
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 927AH8112L / Nitrofurantoin; AYI8EX34EU / Creatinine
  •  go-up   go-down


44. ||||||.... 59%  Zhang Q, Wang C, Wang X, Wu T, Ma Q: [Simultaneous determination of nitrofurantoin and furazolidone in cosmetics using high performance liquid chromatography]. Se Pu; 2009 Mar;27(2):237-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Simultaneous determination of nitrofurantoin and furazolidone in cosmetics using high performance liquid chromatography].
  • A method was developed for the simultaneous determination of nitrofurantoin and furazolidone in cosmetics using reversed-phase high performance liquid chromatography.
  • The linear ranges for nitrofurantoin and furazolidone were 0.1-20 mg/L (r = 0.9999).
  • The method is convenient, rapid, reliable and suitable for the determination of nitrofurantoin and furazolidone in cosmetics.

  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19626857.001).
  • [ISSN] 1000-8713
  • [Journal-full-title] Se pu = Chinese journal of chromatography / Zhongguo hua xue hui
  • [ISO-abbreviation] Se Pu
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


45. ||||||.... 59%  Reynolds TD, Thomas J: Nitrofurantoin related pulmonary disease: a clinical reminder. BMJ Case Rep; 2013;2013
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nitrofurantoin related pulmonary disease: a clinical reminder.
  • It transpired that 4 months prior to the onset of symptoms she had been started on nitrofurantoin for prophylaxis against urinary tract infections.
  • The nitrofurantoin was stopped and she was started on prednisolone.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23729707.001).
  • [ISSN] 1757-790X
  • [Journal-full-title] BMJ case reports
  • [ISO-abbreviation] BMJ Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


46. ||||||.... 58%  Poulsen HO, Johansson A, Granholm S, Kahlmeter G, Sundqvist M: High genetic diversity of nitrofurantoin- or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread. J Antimicrob Chemother; 2013 Sep;68(9):1974-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High genetic diversity of nitrofurantoin- or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread.
  • METHODS: In this study we investigated the clonal structure of 34 strains of E. coli (collected from non-pregnant women aged 18-65 years with uncomplicated UTIs in Europe and Canada) resistant to either of two other common treatment alternatives for uncomplicated UTIs, mecillinam or nitrofurantoin, using multilocus sequence typing (MLST).
  • CONCLUSIONS: The results of this study indicate a low probability of a future clonal spread of resistance to mecillinam and nitrofurantoin.
  • [MeSH-major] Amdinocillin / pharmacology. Drug Resistance, Bacterial. Escherichia coli / classification. Escherichia coli / genetics. Escherichia coli Infections / epidemiology. Genetic Variation. Nitrofurantoin / pharmacology

  • MedlinePlus Health Information. consumer health - E. Coli Infections.
  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23640126.001).
  • [ISSN] 1460-2091
  • [Journal-full-title] The Journal of antimicrobial chemotherapy
  • [ISO-abbreviation] J. Antimicrob. Chemother.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 32887-01-7 / Amdinocillin; 927AH8112L / Nitrofurantoin
  • [Keywords] NOTNLM ; antimicrobial resistance / successful clones / uncomplicated urinary tract infections
  •  go-up   go-down


47. ||||||.... 58%  Pérez M, Real R, Mendoza G, Merino G, Prieto JG, Alvarez AI: Milk secretion of nitrofurantoin, as a specific BCRP/ABCG2 substrate, in assaf sheep: modulation by isoflavones. J Vet Pharmacol Ther; 2009 Oct;32(5):498-502
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Milk secretion of nitrofurantoin, as a specific BCRP/ABCG2 substrate, in assaf sheep: modulation by isoflavones.
  • Nitrofurantoin is a specific BCRP substrate which is actively excreted into milk by this transporter.
  • In this research, we studied nitrofurantoin transport into milk in four experimental groups: G1-calves fed forage with isoflavones; G2-calves fed forage with isoflavones and administered exogenous genistein and daidzein; G3-calves fed forage without isoflavones; G4-calves fed forage without isoflavones and administered exogenous genistein and daidzein.
  • Results show increased levels of nitrofurantoin in milk from calves without isoflavones (G3) and decreased nitrofurantoin residues in milk when isoflavones were present, either by forage (G1 and G2) or by exogenous administration (G4).
  • [MeSH-major] Anti-Infective Agents, Urinary / pharmacokinetics. Genistein / pharmacology. Isoflavones / pharmacology. Milk / chemistry. Nitrofurantoin / pharmacokinetics

  • HSDB. structure - GENISTEIN.
  • HSDB. structure - NITROFURANTOIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19754918.001).
  • [ISSN] 1365-2885
  • [Journal-full-title] Journal of veterinary pharmacology and therapeutics
  • [ISO-abbreviation] J. Vet. Pharmacol. Ther.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 0 / Isoflavones; 6287WC5J2L / daidzein; 927AH8112L / Nitrofurantoin; DH2M523P0H / Genistein
  •  go-up   go-down


48. ||||||.... 57%  López-López L, Rivera-Rodríguez N, Vilá LM: Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus. BMJ Case Rep; 2012;2012
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus.
  • Herein, we report a middle-aged Hispanic woman with long-standing SLE, who developed a TTP-like illness characterised by MAHA and thrombocytopaenia after exposure to nitrofurantoin.
  • To our knowledge, this is the first case that reports the association between nitrofurantoin and a TTP-like presentation.
  • [MeSH-major] Anemia, Hemolytic / chemically induced. Anti-Infective Agents, Urinary / adverse effects. Anti-Infective Agents, Urinary / therapeutic use. Lupus Erythematosus, Systemic / complications. Nitrofurantoin / adverse effects. Nitrofurantoin / therapeutic use. Purpura, Thrombotic Thrombocytopenic / chemically induced. Thrombocytopenia / chemically induced. Urinary Tract Infections / drug therapy


49. ||||||.... 56%  Justiz R, Taylor V, Day M: Neurogenic bladder: a complication after endoscopic adhesiolysis with return of bladder function while using nitrofurantoin. Anesth Analg; 2010 May 1;110(5):1496-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neurogenic bladder: a complication after endoscopic adhesiolysis with return of bladder function while using nitrofurantoin.
  • Three years later, she experienced resolution of the neurogenic bladder symptoms that coincided with the use of the antibiotic nitrofurantoin.
  • With reinstitution of nitrofurantoin, the patient was once again able to void effectively and has been maintained on nitrofurantoin for >3 years.
  • [MeSH-major] Anti-Infective Agents, Urinary / therapeutic use. Nitrofurantoin / therapeutic use. Postoperative Complications / drug therapy. Tissue Adhesions / surgery. Urinary Bladder / physiopathology. Urinary Bladder, Neurogenic / drug therapy. Urinary Bladder, Neurogenic / etiology

  • MedlinePlus Health Information. consumer health - Adhesions.
  • MedlinePlus Health Information. consumer health - After Surgery.
  • HSDB. structure - NITROFURANTOIN.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20304983.001).
  • [ISSN] 1526-7598
  • [Journal-full-title] Anesthesia and analgesia
  • [ISO-abbreviation] Anesth. Analg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Infective Agents, Urinary; 927AH8112L / Nitrofurantoin
  •  go-up   go-down


50. ||||||.... 55%  Lumbiganon P, Villar J, Laopaiboon M, Widmer M, Thinkhamrop J, Carroli G, Duc Vy N, Mignini L, Festin M, Prasertcharoensuk W, Limpongsanurak S, Liabsuetrakul T, Sirivatanapa P, World Health Organization Asymptomatic Bacteriuria Trial Group: One-day compared with 7-day nitrofurantoin for asymptomatic bacteriuria in pregnancy: a randomized controlled trial. Obstet Gynecol; 2009 Feb;113(2 Pt 1):339-45
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] One-day compared with 7-day nitrofurantoin for asymptomatic bacteriuria in pregnancy: a randomized controlled trial.
  • OBJECTIVE: To evaluate whether a 1-day nitrofurantoin regimen is as effective as a 7-day regimen in eradicating asymptomatic bacteriuria during pregnancy.
  • Those who consented were randomly allocated to receive either a 1-day or a 7-day course of 100 mg capsules of nitrofurantoin, which was taken twice daily.
  • CONCLUSION: A 1-day regimen of nitrofurantoin is significantly less effective than a 7-day regimen.
  • [MeSH-major] Anti-Bacterial Agents / administration & dosage. Bacteriuria / drug therapy. Nitrofurantoin / administration & dosage. Pregnancy Complications, Infectious / drug therapy


top


2. Definitions


3. Related RMF webpages


terms of use | advertising programs | contact us
© 2014 RecentMedicalFindings


Connect with the


RMF


audience;




Post your ad here!